X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2512) 2512
male (1893) 1893
adenoma - chemically induced (1858) 1858
female (1828) 1828
mice (1322) 1322
humans (1244) 1244
rats (1199) 1199
adenoma - pathology (843) 843
lung neoplasms - chemically induced (787) 787
liver neoplasms - chemically induced (638) 638
oncology (621) 621
neoplasms, experimental - chemically induced (570) 570
carcinogens (519) 519
adenocarcinoma - chemically induced (513) 513
adult (497) 497
index medicus (467) 467
middle aged (377) 377
cancer (364) 364
rats, inbred f344 (329) 329
tumors (327) 327
carcinogens - toxicity (324) 324
time factors (322) 322
toxicology (302) 302
colonic neoplasms - chemically induced (288) 288
carcinoma, hepatocellular - chemically induced (278) 278
carcinogenesis (270) 270
liver neoplasms - pathology (269) 269
lung neoplasms - pathology (269) 269
adenoma (267) 267
dose-response relationship, drug (254) 254
aged (246) 246
carcinoma - chemically induced (246) 246
adenocarcinoma - pathology (229) 229
liver - pathology (228) 228
adenoma - prevention & control (220) 220
adenoma - genetics (211) 211
liver neoplasms, experimental - chemically induced (209) 209
adenoma - metabolism (207) 207
mice, inbred strains (197) 197
kidney neoplasms - chemically induced (196) 196
mice, inbred c57bl (186) 186
adenoma, bile duct - chemically induced (184) 184
cricetinae (183) 183
disease models, animal (183) 183
pathology (180) 180
body weight - drug effects (176) 176
pregnancy (176) 176
colonic neoplasms - pathology (173) 173
contraceptives, oral - adverse effects (168) 168
diet (165) 165
liver - drug effects (161) 161
rats, inbred strains (159) 159
hyperplasia (146) 146
carcinoma - pathology (144) 144
liver (144) 144
adenomas (143) 143
pancreatic neoplasms - chemically induced (142) 142
endocrinology & metabolism (141) 141
neoplasms, experimental - pathology (141) 141
adenoma, liver cell - chemically induced (138) 138
colorectal cancer (136) 136
precancerous conditions - chemically induced (136) 136
carcinoma, hepatocellular - pathology (130) 130
urethane (130) 130
pituitary neoplasms - chemically induced (127) 127
risk factors (126) 126
mammary neoplasms, experimental - chemically induced (123) 123
mice, inbred a (123) 123
risk (122) 122
carcinoma, squamous cell - chemically induced (118) 118
expression (118) 118
nitrosamines - toxicity (118) 118
research article (116) 116
adenoma - surgery (115) 115
azoxymethane (115) 115
immunohistochemistry (115) 115
carcinogenicity tests (114) 114
hyperplasia - chemically induced (114) 114
mouse (113) 113
adenoma - complications (112) 112
colonic neoplasms - prevention & control (110) 110
administration, oral (109) 109
article (109) 109
mutation (109) 109
pharmacology & pharmacy (109) 109
liver neoplasms, experimental - pathology (108) 108
nitrosamines (108) 108
lung neoplasms - genetics (107) 107
rodents (107) 107
organ size - drug effects (106) 106
kidney neoplasms - pathology (103) 103
papilloma - chemically induced (103) 103
chemoprevention (102) 102
precancerous conditions - pathology (102) 102
sex factors (102) 102
gastroenterology & hepatology (101) 101
rats, sprague-dawley (100) 100
species specificity (98) 98
stomach neoplasms - chemically induced (97) 97
carcinoma (96) 96
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3092) 3092
Russian (99) 99
German (91) 91
French (77) 77
Japanese (35) 35
Italian (23) 23
Spanish (19) 19
Chinese (11) 11
Hungarian (8) 8
Dutch (7) 7
Czech (5) 5
Polish (4) 4
Danish (3) 3
Bulgarian (2) 2
Portuguese (2) 2
Hebrew (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Frontiers in Bioscience - Elite, ISSN 1945-0494, 06/2013, Volume 5, Issue 3, pp. 939 - 946
Primary pulmonary malignancies remain the major source of cancer-related deaths in the Western World. While surgical resection is an efficacious therapy for... 
A/J strain | Carcinogen | Adenoma | Review | Chemoprevention | Animals | Lung Neoplasms - chemically induced | Humans | Mice | Carcinogenesis | Carcinogens - toxicity | Disease Models, Animal
Journal Article
Journal Article
Molecular Carcinogenesis, ISSN 0899-1987, 12/2006, Volume 45, Issue 12, pp. 934 - 942
Inappropriate fibroblast growth factor (FGF) signaling is involved in most tissue‐specific pathologies including cancer. Previously we showed that... 
growth factors | liver adenoma | hepatoma models | receptor switching | transgenic models | tyrosine kinases | hepatocellular carcinoma | Receptor switching | Transgenic models | Liver adenoma | Hepatoma models | Tyrosine kinases | Hepatocellular carcinoma | Growth factors | CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | FIBROBLAST-GROWTH-FACTOR | PROLIFERATION | CANCER | REGULATOR | ONCOLOGY | AUTOCRINE | LIVER | HEPARAN-SULFATE | MICE | RECEPTORS | Receptor, Fibroblast Growth Factor, Type 4 - metabolism | Carcinoma, Hepatocellular - chemically induced | Transcriptional Activation | Fibroblast Growth Factors - genetics | Liver Neoplasms - chemically induced | RNA, Messenger - analysis | Hepatocytes - pathology | Cell Transformation, Neoplastic - chemically induced | Fibroblast Growth Factor 1 - genetics | Fibroblast Growth Factor 1 - antagonists & inhibitors | Hepatocytes - metabolism | RNA, Messenger - metabolism | Cell Transformation, Neoplastic - genetics | Carcinoma, Hepatocellular - genetics | Fibroblast Growth Factor 1 - physiology | Liver Neoplasms - pathology | Fibroblast Growth Factor 2 - physiology | Fibroblast Growth Factors - physiology | Gene Targeting | Liver Neoplasms - genetics | Mice, Transgenic | Carbon Tetrachloride - toxicity | Fibroblast Growth Factor 2 - antagonists & inhibitors | Animals | Fibroblast Growth Factor 2 - genetics | Receptor, Fibroblast Growth Factor, Type 4 - agonists | Carcinoma, Hepatocellular - pathology | Mice | Fibroblast Growth Factors - antagonists & inhibitors | Cell Transformation, Neoplastic - pathology
Journal Article
Cancer Prevention Research, ISSN 1940-6207, 12/2013, Volume 6, Issue 12, pp. 1251 - 1261
Estrogen receptor (ER)-beta signaling is associated positively in colon tumor progression, whereas down-regulation or loss of function of retinoid X receptor... 
ESTROGEN-RECEPTOR-BETA | BREAST-CANCER | LGD1069 TARGRETIN | PLUS PROGESTIN | ER-BETA | ONCOLOGY | PREVENTION | HORMONE REPLACEMENT THERAPY | POSTMENOPAUSAL WOMEN | EXPRESSION | COLORECTAL-CANCER INCIDENCE | Raloxifene Hydrochloride - therapeutic use | Apoptosis - drug effects | Colonic Neoplasms - prevention & control | Tissue Array Analysis | Adenocarcinoma - chemically induced | Humans | Middle Aged | Rats, Inbred F344 | Adenoma - prevention & control | Tetrahydronaphthalenes - therapeutic use | Colonic Neoplasms - chemically induced | Male | Azoxymethane - toxicity | Colonic Neoplasms - metabolism | Immunoenzyme Techniques | Adenoma - metabolism | Estrogen Receptor beta - metabolism | Adenocarcinoma - metabolism | Neoplasm Grading | Biomarkers, Tumor - metabolism | Adult | Female | Tumor Cells, Cultured | Drug Therapy, Combination | Estrogen Receptor beta - antagonists & inhibitors | Real-Time Polymerase Chain Reaction | Retinoid X Receptors - metabolism | Anticarcinogenic Agents - therapeutic use | RNA, Messenger - genetics | Rats | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Adenocarcinoma - prevention & control | Animals | Estrogen Antagonists - therapeutic use | Retinoid X Receptors - agonists | Aged | Biomarkers, Tumor - genetics | Adenoma - chemically induced | ER-β | Bexarotene | colorectal cancer | Rexinoid | SERM | raloxifene | RXR-α
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 09/2012, Volume 122, Issue 9, pp. 3127 - 3144
The chemokine receptor CXCR2 is a key mediator of neutrophil migration that also plays a role in tumor development. However, CXCR2 influences tumors through... 
ATHEROSCLEROTIC LESIONS | COLON-CANCER | MEDICINE, RESEARCH & EXPERIMENTAL | TUMOR-NECROSIS-FACTOR | IMMUNE CELLS | INTESTINAL NEOPLASIA | PROSTATE-CANCER | SKIN CARCINOGENESIS | RECEPTOR D6 | MYELOID CELLS | BEARING MICE | Dextran Sulfate | Tetradecanoylphorbol Acetate | Adenocarcinoma - pathology | Colitis - pathology | Colonic Neoplasms - chemically induced | Mice, 129 Strain | Receptors, Interleukin-8B - antagonists & inhibitors | Receptors, Interleukin-8B - deficiency | Colonic Neoplasms - metabolism | Adenoma - metabolism | Adenocarcinoma - metabolism | Azoxymethane | Colitis - chemically induced | Statistics, Nonparametric | Papilloma - pathology | Precancerous Conditions - pathology | Neutrophils - metabolism | Papilloma - chemically induced | Papilloma - metabolism | Skin Neoplasms - pathology | Dermatitis, Contact - pathology | Gene Expression | Neutrophils - enzymology | Mice, Inbred C57BL | Skin Neoplasms - chemically induced | Tumor Burden | Chemokines, CXC - genetics | Chemokines, CXC - secretion | Mice, Knockout | Skin Neoplasms - metabolism | Animals | Cell Transformation, Neoplastic | Adenoma - secretion | Chemokines, CXC - metabolism | Receptors, Interleukin-8B - genetics | Animals, Inbred Strains | 9,10-Dimethyl-1,2-benzanthracene | Mice | Mice, Inbred BALB C | Precancerous Conditions - chemically induced | Colonic Neoplasms - secretion | Adenoma - chemically induced | Peroxidase - metabolism | Care and treatment | Cancer cells | Neutrophils | Papilloma | Genetic aspects | Diagnosis | Adenoma | Research | Gene expression
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 1/2010, Volume 102, Issue 1, pp. 14 - 25
Due to the aging of the populations of developed countries and a common occurrence of risk factors, it is increasingly probable that a patient may have both... 
DOXORUBICIN-INDUCED CARDIOTOXICITY | TRASTUZUMAB-RELATED CARDIOTOXICITY | ONCOLOGY | SPORADIC COLORECTAL ADENOMAS | VASCULAR-DISRUPTING AGENTS | TYROSINE KINASE INHIBITOR | N-ACETYLCYSTEINE | DAUNORUBICIN-INDUCED CYTOTOXICITY | HIGH-DOSE CHEMOTHERAPY | EARLY BREAST-CANCER | ATRIAL-FIBRILLATION | Atrial Fibrillation - chemically induced | Cardiovascular Diseases - prevention & control | Humans | Patient Care Team | Atrial Fibrillation - physiopathology | Ventricular Dysfunction, Left - chemically induced | Flavonoids - therapeutic use | Cardiotonic Agents - therapeutic use | Venous Thromboembolism - prevention & control | Cardiovascular System - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Antineoplastic Agents - adverse effects | Hypertension - chemically induced | Hypertension - prevention & control | Polyphenols | Free Radical Scavengers - therapeutic use | Acetylcysteine - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Diseases - diagnosis | Heart - physiopathology | Cardiovascular Diseases - physiopathology | Stroke Volume - drug effects | Anticoagulants - therapeutic use | Cardiovascular System - drug effects | Hypertension - physiopathology | Ventricular Dysfunction, Left - physiopathology | Ventricular Dysfunction, Left - prevention & control | Cardiovascular Diseases - microbiology | Animals | Blood Coagulation - drug effects | Venous Thromboembolism - physiopathology | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Phenols - therapeutic use | Venous Thromboembolism - chemically induced | Heart - drug effects | Cardiovascular Diseases - chemically induced | Atrial Fibrillation - prevention & control | Antimitotic agents | Complications and side effects | Aging | Physiological aspects | Dosage and administration | Research | Cardiovascular diseases | Antineoplastic agents | Risk factors | Index Medicus | Review
Journal Article